29.98 USD
↗ 0.00 (0.00%)AT CLOSE (AS OF 07:44 PM EDT)
Rigel Pharmaceuticals Inc. (New)
RIGLNASDAQ • USD
Market: CLOSED
Open?$30.33
High?$30.69
Low?$29.74
Prev. Close?$29.93
Volume?498.4K
Avg. Volume?412.8K
VWAP?$30.01
Rel. Volume?1.21x
Bid / Ask
Bid?$27.92 × 100
Ask?$30.20 × 100
Spread?$2.28
Midpoint?$29.06
Valuation & Ratios
Market Cap?553.8M
Shares Out?18.5M
Float?16.6M
Float %?89.5%
P/E Ratio?1.52
P/B Ratio?1.38
EPS?$19.69
Dividend?0.00%
Ex-Dividend?N/A
Rigel Pharmaceuticals Inc. (New) (RIGL) is currently trading at $29.98. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include exceptional Return on Equity (91.1%) and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
Themes
Address
611 GATEWAY BOULEVARD, SUITE 900
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-624-1100
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-624-1100
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?39
Momentum?35
Short Sent.?45
Piotroski F-Score?4/9Mixed
Altman Z-Score?2.11Grey
Confidence?78%Moderate
Short InterestSqueeze Risk
Short % of Float?23.83%Squeeze Risk
Short Interest?3.9M
Days to Cover?7.5
Free Float16.6M
Avg Daily Volume527.0K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.62Strong
Quick Ratio?2.48Strong
Cash Ratio?0.27Low
Debt/Equity?0.11Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?1.5CHEAP▾
Peers100
S&P97
P/B?1.38CHEAP▾
Peers100
S&P90
P/S?1.85CHEAP▾
Peers100
S&P70
P/FCF?7.0CHEAP▾
Peers100
S&P97
EV/EBITDA?4.5CHEAP▾
Peers100
S&P97
EV/Sales?1.92CHEAP▾
Peers100
S&P76
Returns & Efficiency
ROE?91.1%STRONG▾
Peers50
S&P97
ROA?72.2%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$79.3M
Enterprise Value?$574.2M
Fundamentals ratios updated end of day